/
The rat formalin test: Can it predict neuropathic pain treatments? A. Ellis, N. Benson, The rat formalin test: Can it predict neuropathic pain treatments? A. Ellis, N. Benson,

The rat formalin test: Can it predict neuropathic pain treatments? A. Ellis, N. Benson, - PDF document

karlyn-bohler
karlyn-bohler . @karlyn-bohler
Follow
442 views
Uploaded On 2015-07-22

The rat formalin test: Can it predict neuropathic pain treatments? A. Ellis, N. Benson, - PPT Presentation

P roceedin g s o f Measurin g Behavior 2008 Maastricht The Netherlands Au g ust 2629 2008 324 Eds AJ Spink MR Ballinti j n ND Bo g ers F Grieco LWS Loi j ens LPJJ Noldus G ID: 89791

P roceedin g s o f Measurin g Behavior 2008

Share:

Link:

Embed:

Download Presentation from below link

Download Pdf The PPT/PDF document "The rat formalin test: Can it predict ne..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

The rat formalin test: Can it predict neuropathic pain treatments? A. Ellis, N. Benson, I. MachPfizer Global Research and Development, Sandwich, UK, amanda.ellis2@pfizer.com Widely used, the formalin test is a tonic model of continuous pain resulting from formalin-induced tissue injury. It is a useful model, particularly for the screening of novel compounds, since it encompasses inflammatory, neurogenic, and central mechanisms of nociception [5,6]. Reports can vary widely with regard to concentration of formalin (itself a 37% dilute solution of formaldehyde) as well as the recording and characterisation of resultant pain behaviours in rats [4,5,6]. P roceedin g s o f Measurin g Behavior 2008 (Maastricht, The Netherlands, Au g ust 26-29, 2008) 324 Eds. A.J. Spink, M.R. Ballinti j n, N.D. Bo g ers, F. Grieco, L.W.S. Loi j ens, L.P.J.J. Noldus, G. Smit, and P.H. Zimmerman 1.Dixit, R., Bhargava, V.K., Kaur, N. (1999). Antinociceptive effect of gabapentin in the formalin test. Methods and Findings ,481-482. 2.Iyengar, S., Webster, A.A., Hemricke-Luecke, S.K., Yu Xu, J., Simmons, R.M.A. (2004). Efficacy of Duloxetine, a Potent and Balanced Serotonin-Norepinephrine Reuptake Inhibitor in The Journal of Pharmacology ,576-584. 3.Jett, M.F., McGuirk, J., Waligora, D., Hunter, J.C. (1997). The effects of mexiletine, desipramine, and fluoxetine in rat models involving central sensitisation. , 161-169. 4.Kaneko, M., Hammond, D.L. (1997). Role of Spinal -Aminobutyric Acid Receptors in Formalin-Induced The Journal of Pharmacology and ,928-938. 5.Lee, I.O., Kong, M.H., Kim, N.S., Choi, Y.S., Lim, S.H., Lee, M.K. (2000). Effect of different concentrations and volumes of formalin on pain response in rats. Acta Anaesthesiologica Sinica, 59-64. 6.Tjølsen, A., Berge, O.G., Hunskaar, S., Rosland, J.H., Hole, K. (1992). The formalin test: an evaluation of the method. 5-17. 7.Vissers, K.C.P., Geenen, F., Biermans, R., Meert, T.F. (2006). Pharmacological correlation between the formalin test and the neuropathic pain behaviour in different species with chronic Pharmacology, Biochemistry and Behaviour, 479-486. P roceedin g s o f Measurin g Behavior 2008 (Maastricht, The Netherlands, Au g ust 26-29, 2008) Eds. A.J. Spink, M.R. Ballinti j n, N.D. Bo g ers, F. Grieco, L.W.S. Loi j ens, L.P.J.J. Noldus, G. Smit, and P.H. Zimmerman 325